Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Nilsson

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Scientific Reports|October 13, 2021
Antibodies against phosphorylcholine in hospitalized versus non-hospitalized obese subjectsAmra Jujić, J Korduner, H Holm, et al.
Journal of Internal Medicine|March 25, 2005
Weight change and mortality: the Nord-Trøndelag Health StudyW B Drøyvold, T I Lund Nilsen, S Lydersen, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 13, 2011
Gender-specific differences in carotid intima-media thickness and its progression over three years: a multicenter European studyM Kozàkovà, C Palombo, C Morizzo, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 31, 2008
The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle-aged Swedish individualsM Montagnana, C Fava, P M Nilsson, et al.
Scandinavian Journal of Rheumatology|June 30, 2025
Genetically predicted serum urate and cancer risk: a Mendelian randomization studyT Fatima, M Dehlin, S Burgess, et al.
Diabetes, Obesity & Metabolism|March 22, 2008
Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemiaW A Scherbaum, A Schweizer, A Mari, et al.
International Journal of Obesity (2005)|May 23, 2012
Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohortS Enhörning, L Bankir, N Bouby, et al.
Diabetologia|April 18, 2009
Assessing the effect of interaction between an FTO variant (rs9939609) and physical activity on obesity in 15,925 Swedish and 2,511 Finnish adultsA Jonsson, F Renström, V Lyssenko, et al.
Journal of Human Hypertension|April 20, 2007
Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetesP A Sarafidis, A N Lasaridis, P M Nilsson, et al.
International Journal of Obesity (2005)|September 17, 2015
Inverse relationship between a genetic risk score of 31 BMI loci and weight change before and after reaching middle ageG Rukh, S Ahmad, U Ericson, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Scientific Reports|October 13, 2021
Antibodies against phosphorylcholine in hospitalized versus non-hospitalized obese subjectsAmra Jujić, J Korduner, H Holm, et al.
Journal of Internal Medicine|March 25, 2005
Weight change and mortality: the Nord-Trøndelag Health StudyW B Drøyvold, T I Lund Nilsen, S Lydersen, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 13, 2011
Gender-specific differences in carotid intima-media thickness and its progression over three years: a multicenter European studyM Kozàkovà, C Palombo, C Morizzo, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 31, 2008
The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle-aged Swedish individualsM Montagnana, C Fava, P M Nilsson, et al.
Scandinavian Journal of Rheumatology|June 30, 2025
Genetically predicted serum urate and cancer risk: a Mendelian randomization studyT Fatima, M Dehlin, S Burgess, et al.
Diabetes, Obesity & Metabolism|March 22, 2008
Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemiaW A Scherbaum, A Schweizer, A Mari, et al.
International Journal of Obesity (2005)|May 23, 2012
Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohortS Enhörning, L Bankir, N Bouby, et al.
Diabetologia|April 18, 2009
Assessing the effect of interaction between an FTO variant (rs9939609) and physical activity on obesity in 15,925 Swedish and 2,511 Finnish adultsA Jonsson, F Renström, V Lyssenko, et al.
Journal of Human Hypertension|April 20, 2007
Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetesP A Sarafidis, A N Lasaridis, P M Nilsson, et al.
International Journal of Obesity (2005)|September 17, 2015
Inverse relationship between a genetic risk score of 31 BMI loci and weight change before and after reaching middle ageG Rukh, S Ahmad, U Ericson, et al.
Pageof 10